Dark

Check out our Dark Pool Levels

NAMS
NewAmsterdam Pharma Company N.V.
stock NASDAQ

At Close

Apr 14, 2026 3:59:54 PM EDT

34.45USD-4.966%(-1.80)1,619,705

0.00Bid 0.00Ask 0.00Spread

Pre-market

Apr 14, 2026 9:12:30 AM EDT

36.26USD+0.028%(+0.01)8,772

After-hours

Apr 14, 2026 4:00:30 PM EDT

34.44USD-0.029%(-0.01)13,319

OverviewOptionsHistoricalExchangesShortsTrends

NAMS Reddit Mentions

Subreddits

Limit Labels Price

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.

Take me to the API

NAMS Specific Mentions

As of Apr 15, 2026 3:25:53 AM EDT (8 minutes ago)

Includes all comments and posts. Mentions per user per ticker capped at one per hour.

5 days ago • u/Zipski577 • r/ValueInvesting • there_were_people_here_telling_others_to_take_out • C

I am very long in TVTX right now. They have binary on Monday on an FDA decision to gain approval for a second indication on their drug Filspari that will be huge for them. Big position for me that I want to size even more but need to do some more work on it tonight. Right now I give it 80%+ chance and probably re-rates to $40+ immediately.
I think RVMD and GPCR have a pretty high chance of being bought out this year by a big pharma. GPCR is also in obesity like ALT
Other stocks that don’t have catalysts until Q3 but I think are strong and currently have a lot of upside are PHVS and AVBP.
Other Phase 2/3 names I own are NAMS, ARWR, AXSM, DNTH, and RLAY.
Some higher risk, early science “penny stocks” I like right now are IVVD, OVID, PALI, ALLO, CNTX
And the “safest” commercial companies that are strong longer term I think are ASND, INSM, PTGX and UTHR.

5 days ago • u/Zipski577 • r/ValueInvesting • there_were_people_here_telling_others_to_take_out • C

I am very long in TVTX right now. They have binary on Monday on an FDA decision to gain approval for a second indication on their drug Filspari that will be huge for them. Big position for me that I want to size even more but need to do some more work on it tonight. Right now I give it 80%+ chance and probably re-rates to $40+ immediately.
I think RVMD and GPCR have a pretty high chance of being bought out this year by a big pharma. GPCR is also in obesity like ALT
Other stocks that don’t have catalysts until Q3 but I think are strong and currently have a lot of upside are PHVS and AVBP.
Other Phase 2/3 names I own are NAMS, ARWR, AXSM, DNTH, and RLAY.
Some higher risk, early science “penny stocks” I like right now are IVVD, OVID, PALI, ALLO, CNTX
And the “safest” commercial companies that are strong longer term I think are ASND, INSM, PTGX and UTHR.

Share